Response of the ENPP1-Deficient Skeletal Phenotype to Oral Phosphate Supplementation and/or Enzyme Replacement Therapy: Comparative Studies in Humans and Mice.
Ferreira CR, Kavanagh D, Oheim R, Zimmerman K, Stürznickel J, Li X, Stabach P, Rettig RL, Calderone L, MacKichan C, Wang A, Hutchinson HA, Nelson T, Tommasini SM, von Kroge S, Fiedler IA, Lester ER, Moeckel GW, Busse B, Schinke T, Carpenter TO, Levine MA, Horowitz MC, Braddock DT.
Ferreira CR, et al.
J Bone Miner Res. 2021 May;36(5):942-955. doi: 10.1002/jbmr.4254. Epub 2021 Feb 18.
J Bone Miner Res. 2021.
PMID: 33465815
Free PMC article.
In addition, conventional therapy was associated with the development of medullary nephrocalcinosis in half of the treated patients. Similar to Enpp1(asj/asj) mice on normal chow and to patients with mono- and biallelic ENPP1 mutations, 5-week-old Enpp1(asj/asj) mic …
In addition, conventional therapy was associated with the development of medullary nephrocalcinosis in half of the treated pat …